The historic rise of Viagra has consistently remained a example of pharmaceutical success, but its legacy within the broader industry now raises questions about future returns . Alternative versions are undercutting market share, prompting concerns that betting on companies heavily reliant to Viagra's previous influence could be a problematic strat